Cystic fibrosis and diabetes: new study aims to uncover hidden links
NCT ID NCT07442682
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is observing 162 adults with cystic fibrosis at a Belgian hospital to see how having diabetes affects their quality of life, lung function, and nutrition. Researchers will compare those with and without diabetes using questionnaires and breathing tests. The goal is to gather information, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand how diabetes impacts cystic fibrosis patients, leading to improved care and monitoring.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test any new therapy, so direct patient benefits are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS (CF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Erasme - HUB 808 route de Lennik 1070 Brussels Belgium
Brussels, 1070, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?
- Could diabetes be silently damaging your hearing?
- Press play on better health: could recording doctor visits boost Self-Care in seniors?
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- A simple card game could transform diabetes care
- Can a new injection help tackle obesity and diabetes? a safety trial begins